ECCMID 26th (2016)

Title Content type
Allometric scaling and the chimpanzee as a surrogate for human pharmacokinetics of CD101, a novel echinocandin (click for details)
Micafungin serum levels in critically ill patients on continous venovenous haemodialysis using high cut-off membranes (CVVHD-HCM) (click for details)
Pharmacokinetics and absolute bioavailability of voriconazole administred through a nasogastric tube with continuous enteral feeding to critically ill ventillated patients (click for details)
Activity against fungi of nonhydrolytic synthesized TiO2 (click for details)
The novel orotomide F901318 demonstrates potent in vitro antifungal activity against Lomentospora and Scedosporium species (click for details)
Differences in cytokine levels in diabetic versus non-diabetic mice challenged with Candida albicans and treated with liposomal amphotericin B (click for details)
Subinhibitory concentrations of micafungin exert species-dependent differential effects on Candida and modulate the antifungal activity of human neutrophils against mature biofilms (click for details)
Economic analysis of diagnostic-driven versus empirical strategies for the treatment of immunocompromised patients with suspected fungal infections in Egypt (click for details)
Anti-biofilm properties of Peganum harmala against Candida albicans (click for details)
Once-weekly dosing requires a proportionally higher dosage of micafungin for treatment of experimental disseminated candidiasis caused by Candida glabrata in persistently neutropenic rabbits (click for details)

Pages

Subscribe to ECCMID 26th (2016)